ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ORTX Orchard Therapeutics PLC

16.70
0.00 (0.00%)
2024年5月20日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Orchard Therapeutics PLC ORTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 16.70 09:00:00
始値 安値 高値 終値 前日終値
16.70 16.70
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0720:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
2024/5/0320:00GLOBEOrchard Therapeutics Co-founder and Chief Executive Officer..
2024/3/2020:00GLOBEOrchard Therapeutics Outlines U.S. Launch Plans for..
2024/3/1904:41GLOBEOrchard Therapeutics Receives FDA Approval of Lenmeldy™..
2024/2/1511:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0604:39EDGAR2Form 15-12G - Securities registration termination [Section..
2024/2/0521:00GLOBEOrchard Therapeutics Announces First Patient Randomized in..
2024/2/0221:00GLOBEOrchard Therapeutics Announces Multiple Presentations at the..
2024/1/3114:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/2521:00GLOBEOrchard Therapeutics Announces Agreement with the Beneluxa..
2024/1/2507:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2507:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2507:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/1/2506:28EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/1/2506:17EDGAR2Form 8-K - Current report
2024/1/2419:00GLOBEKyowa Kirin successfully completes acquisition of Orchard..
2024/1/2306:10EDGAR2Form 8-K - Current report
2023/12/2006:49EDGAR2Form 8-K - Current report
2023/12/1121:00GLOBEOrchard Therapeutics Receives Swissmedic Approval for..
2023/12/0906:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/0906:37EDGAR2Form 8-K - Current report
2023/12/0106:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/0106:06EDGAR2Form 8-K - Current report
2023/11/3021:00GLOBEOrchard Therapeutics Receives U.S. FDA Fast Track..
2023/11/2121:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/2121:51EDGAR2Form 8-K - Current report
2023/11/1706:45EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
2023/11/1321:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1321:05EDGAR2Form 8-K - Current report
2023/11/1321:00GLOBEOrchard Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0406:11EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2023/10/2705:35EDGAR2Form 8-K - Current report
2023/10/2620:00GLOBEOrchard Therapeutics Announces Presentation of Additional..
2023/10/2420:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
2023/10/1805:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/10/0606:26EDGAR2Form DEFA14C - Additional information statement materials,..
2023/10/0605:48EDGAR2Form DEFA14C - Additional information statement materials,..
2023/10/0605:45EDGAR2Form DEFA14C - Additional information statement materials,..
2023/10/0605:43EDGAR2Form DEFA14C - Additional information statement materials,..
2023/10/0605:40EDGAR2Form DEFA14C - Additional information statement materials,..
2023/10/0522:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/10/0522:05EDGAR2Form 8-K - Current report
2023/10/0520:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
2023/10/0516:35GLOBEKyowa Kirin to Acquire Orchard Therapeutics
2023/9/1820:07EDGAR2Form 8-K - Current report
2023/9/1820:00GLOBEOrchard Therapeutics Announces Acceptance of Biologics..
2023/8/3120:00GLOBEOrchard Therapeutics Announces Presentation of Data..
2023/8/2205:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1106:04EDGAR2Form S-8 - Securities to be offered to employees in employee..

最近閲覧した銘柄

Delayed Upgrade Clock